Gonadal suppression alters axillary steroid secretions in men, but does that affect olfactory social signaling?
Background and objective: Luteinizing hormone-releasing hormone agonists (LHRHa) suppress gonadal hormone production and are commonly used to treat prostate cancer (PC) in men and conditions ranging from uterine fibroids to estrogen-sensitive cancers in women. They are also used to delay sexual...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MRE Press
2021-07-01
|
Series: | Journal of Men's Health |
Subjects: | |
Online Access: | https://oss.jomh.org/jomh/article/20210630-328/pdf/JOMH2021022501.pdf |